A Two Comparator, Controlled Phase 3 Study in Patients With and Without Evaporative Dry Eye

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Omega 3 (OM3) Tear is a new unit dose emulsion, containing flaxseed/castor oil, which is being developed by Allergan. It is desirable to understand the effect that this new emulsion has on tear film evaporation and tear lipid profile via interferometry, in patients with evaporative dry eye (EDE) and those without (non-EDE). It would also be valuable to evaluate the retention time of the lipid components of the new emulsion via tear collection and analysis in EDE and non-EDE patients
Epistemonikos ID: 6fa7519ea5c8965255c32711166bad44a0b4d15c
First added on: May 17, 2024